MedTrace Logo

Multicenter Validation of the Salivary miRNA Signature of Endometriosis

NCT05244668 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1140

Last updated 2026-03-27

No results posted yet for this study

Summary

ENDOmiARN Salive Test is a multicentre external validation study of a salivary signature of endometriosis carried out in France in Obstetrics and Reproductive Medicine departments, in order to evaluate its performance and discuss its use in clinical practice. The clinical application is to significantly reduce the time to diagnosis and improve the care pathway for endometriosis.

The study population is made up of women aged 18 to 43 years with formally diagnosed endometriosis or suspected endometriosis who are already receiving either medical (MAP) or surgical treatment as part of their routine care.

The patients concerned by the study are managed without any change in the care pathway, nor any change in the therapeutic indications, nor any change in the diagnostic examinations (imaging or biology) required according to the context, which are carried out in accordance with the HAS recommendations.

In this study, the management and follow-up of patients :

* Are not imposed by the study: the doctor remains free to make medical prescriptions (treatments and examinations) and to determine the interval between consultation visits,
* Are not modified in comparison with the usual follow-up, except for the performance of :

* Collection of saliva
* Electronic collection of the answers to the questionnaires completed by the patient

Conditions

  • Endometriosis

Sponsors & Collaborators

  • Monitoring Force Group

    collaborator INDUSTRY

  • iGenSeq

    collaborator UNKNOWN

  • ZIWIG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2023-01-06
Completion
2026-02-28

Countries

  • Canada
  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05244668 on ClinicalTrials.gov